1. Home
  2. Nation
  3. Bharat Biotech prepares nasal corona vax, gets regulatory approval for Phase II trial

Bharat Biotech prepares nasal corona vax, gets regulatory approval for Phase II trial

By Ruchi Upadhyay 
Updated Date

New Delhi: India is going to get another vaccine soon to deal with the corona epidemic. This vaccine (Corona Vaccine) can be given as a drop from the nose.

Also Read :- India@75: Bharat Biotech finishes clinical trials for BBV154 intranasal COVID-19 vaccine; Calls it safe

Bharat Biotech is developing vaccine

According to the information, this vaccine is being developed by Bharat Biotech. The company has got approval for the second phase trial of this vaccine. Regulatory approval has been received for clinical trials. The Department of Biotechnology (DBT) said that the first phase of trial of this drug was done on people aged 18 to 60 years. which has been a complete success.

first nasal vaccine

DBT said, ‘This is the first nasal vaccine from Bharat Biotech to be given through the nose. Which has got regulatory approval for Phase II trials. With this, DBT had said in a statement that the company has got approval for Phase II and III trials. This is the first such corona vaccine, which will be tried on humans in India. The company got its technology from Washington University in St. Louis.

Also Read :- For the 2nd consecutive day, India records over 20,000 new cases, 54 fatalities in past 24 hours

No side effects in the first phase

DBT said, ‘The company has informed that the body of people involved in the first phase trial readily accepted the dose of vaccines. No side effects are known from anywhere.’ The vaccine has been found safe in earlier studies as well. DBT said that in the study on animals, this vaccine was successful in producing high levels of antibodies.

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...